Roskilde, Denmark

Marianne Vind Sorensen

This inventor holds 1 USPTO granted patent. Top assignee: Novozymes Adenium Biotech A/s. Active years: 2012.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Marianne Vind Sorensen

Introduction

Marianne Vind Sorensen is a notable inventor based in Roskilde, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial agents. Her work has implications for various applications in health and agriculture.

Latest Patents

Marianne holds a patent for "Polypeptides having antimicrobial activity and polynucleotides encoding same." This invention relates to isolated polypeptides that exhibit antimicrobial properties, as well as the isolated polynucleotides that encode these polypeptides. The patent also encompasses nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides, along with methods for producing and utilizing the polypeptides.

Career Highlights

Marianne is currently associated with Novozymes Adenium Biotech A/S, a company renowned for its focus on biotechnology and enzyme production. Her role at the company allows her to leverage her expertise in developing innovative solutions that address pressing challenges in various industries.

Collaborations

Throughout her career, Marianne has collaborated with esteemed colleagues, including Per Holse Mygind and Mogens Trier Hansen. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological advancements.

Conclusion

Marianne Vind Sorensen's contributions to the field of biotechnology, particularly through her patent on antimicrobial polypeptides, highlight her innovative spirit and dedication to advancing science. Her work continues to inspire future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…